Related Experiment Video

Updated: Mar 3, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.8K

Supplementary data: Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer

Victor A McPherson1, George Rodrigues2, Glenn Bauman2

  • 1Division of Urology.

Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|April 27, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.2K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Related Experiment Videos

Last Updated: Mar 3, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.8K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.2K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K

Articles linked to this work by shared authors, journal, and citation graph.

Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Phase 1/2 Trial of Durvalumab Plus Tremelimumab and Stereotactic Body Radiation Therapy for Metastatic Head and Neck Carcinoma.

International journal of radiation oncology, biology, physics·2026

What Is the Impact of Treatment De-Escalation on Patient-Reported Outcomes in Patients With T1-T2 Oropharyngeal Cancers? A Secondary Analysis of the ORATOR Studies.

International journal of radiation oncology, biology, physics·2026

Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer.

Cell reports. Medicine·2026

Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World Analysis.

Clinical genitourinary cancer·2026

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline Amendment (2026).

The Journal of urology·2026

Successes and challenges in developing a magnetic resonance imaging-transrectal ultrasound machine fusion prostate biopsy service.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026

18F-labeled prostate-specific membrane antigen positron emission tomography/computed tomography vs. magnetic resonance imaging in diagnosis of prostate cancer A meta-analysis.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026

Positive surgical margins after robot-assisted radical prostatectomy Long-term oncologic consequences.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026

Porcine-derived materials in urology Practical ethical guidance for caring for Muslim and Jewish patients.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026

Comparison of inflammation-based biomarkers in metastatic testicular cancer at initial diagnosis.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026

Morphologic and urodynamic predictors of renal scarring in pediatric neurogenic bladder A cross-sectional study.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us